Objective: Episodes of acute adrenal insufficiency (AI)/adrenal crises (AC) are a serious consequence of congenital adrenal hyperplasia (CAH). This study aimed to assess morbidity from acute illness in CAH and identify factors associated with use of IV hydrocortisone, admission and diagnosis of an AC.
| INTRODUC TI ON
Congenital adrenal hyperplasia (CAH) is the most common cause of primary adrenal insufficiency (AI) in children. [1] [2] [3] In Australia, the estimated CAH incidence is about one in 15 000, which is comparable to that in other countries. [1] [2] [3] [4] Approximately 95% of affected children have a deficiency of the enzyme 21-hydroxylase from the autosomal inheritance of inactivating mutations in both CYP21A2 alleles. This results in an impaired biosynthesis and secretion of cortisol, with or without aldosterone deficiency, in addition to elevated levels of adrenal androgens. 3, [5] [6] [7] Treatment of CAH involves the administration of glucocorticoid, both as a replacement therapy and to suppress ACTH stimulation, thereby reducing excess adrenal androgen production. 3, 5, 6 Fludrocortisone is also used to treat aldosterone deficiency.
All children with CAH are at higher risk of morbidity and mortality, some of which is attributable to potentially fatal adrenal crises (ACs). 5, 6, [8] [9] [10] These acute events have an estimated incidence of between 4.9 and 10 ACs per 100 patient-years. 10, 11 ACs are characterized by hypotension, electrolyte abnormalities, hypoglycaemia, vomiting, abdominal pain and a reduced level of consciousness. They occur when the physiological requirement for cortisol is greater than the amount in the circulation, typically during periods of physiological stress, such as an infection. 1, 3, 5, 7 Children with the more severe salt-wasting phenotypes are at a heightened AC risk. Those with less severe forms are also vulnerable during stress due to glucocorticoidrelated suppression of the hypothalamic-pituitary axis.
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Cortisol dose escalation is regarded as the cornerstone of AC prevention in all forms of AI, including CAH. [13] [14] [15] [16] Parents and guardians are taught to increase their child's dose of oral glucocorticoid during intercurrent illness or to administer an intramuscular (IM) injection when oral glucocorticoid therapy cannot be taken or absorbed. However, efforts by health professionals to educate carers and patients about the importance of stress dosing have not resulted in the elimination of ACs. [17] [18] [19] Indeed, recent studies have
shown that AC events continue to occur, even among well-educated AI patients.
17,18
The reasons for the continued incidence of ACs in children with CAH are unknown. Various factors other than the effectiveness of AC prevention programmes, such as psychosocial and cultural aspects, health service availability and clinical practices, have been postulated but the basis for their continued occurrence remains unclear. 9, 17, 20, 21 The aim of this study was to investigate the frequency, causes, severity and management of acute illness in a large sample of patients with CAH who presented to hospital.
| SUBJEC TS AND ME THODS
Three paediatric hospitals provide specialist health care to the 
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The MRNs of all children in each hospital who had at least one admission in which there was a record of a principal or comorbid diagnosis coded under the rubric E25.0 (adrenogenital disorders associated with enzyme deficiency) were identified. 23 All attendances at accident and emergency and admissions to hospital between January 2000 and December 2015 for patients up to 18 years of age were included. Only those children who were on glucocorticoid replacement therapy and had an acute medical (nonsurgical) illness that resulted in an unplanned attendance at hospital were selected for this analysis.
All records were accessed electronically except for some of the earliest records for Hospital B, which were paper-based.
Demographic information and data on the reason for attendance, type and length of stay, presenting symptoms and signs, diagnosis, use of stress dosing and management were collected.
Ethics approval was granted by the Human Research and Ethics
Committees of the Sydney Children's Hospital Network (SCHN), John Hunter Children's Hospital and The University of Notre Dame, Australia.
| Data management
Some symptoms were not documented in some medical records, possibly through omission. Where this information was not found, it was assumed that the symptom was not part of that child's dosing prior to hospital than other age groups. Experience with acute episodes improves self-management of CAH in the context of acute illness in educated patient populations.
K E Y W O R D S
21-hydroxylase deficiency, adrenal crisis, adrenal insufficiency presenting problem and that symptom was classified as absent.
Similarly, where there was no blood chemistry, it was assumed that this represented a clinical decision not to take blood as the child was relatively well and these records were coded as nor- (n = 124) for Hospital A and 77.2% (n = 40) for Hospital B. Where these data were missing, the corresponding record was coded as not stress dosed. One record stated that stress dosing had been used but the type was not specified.
| Statistical analysis
Chi-square and independent t tests were used to assess group differences. Stepwise logistic regression models were developed to identify predictors of an AC diagnosis; hospital admission; the use of any form of stress dose; oral stress dose use only; IM hydrocortisone administration; and the use of IV hydrocortisone in hospital.
Statistical tests were conducted using spss (IBM spss Statistics for Mac, version 24.0, Armonk, NY, USA). A P-value of <0.05 was considered significant.
| RE SULTS
There were 321 presentations for treatment of an acute medical illness by 75 children with CAH during the study period, corresponding to a median of 3 (IQR 2-7) presentations per child. Sixty (80.0%) of these children had salt-wasting CAH. Two-thirds (66.7%, n = 214) of the presentations were to the metropolitan hospitals [157 (48.9%) to
Hospital A and 57 (17.8%) to Hospital B] and the remainder (n = 107, 33.3%) were to the regional hospital (C). Two-thirds (66.4%) of the attendances resulted in admission; IV hydrocortisone was administered to 158 (49.2%) patients; and the median length of stay was 2 (IQR 1-3) days. An AC was recorded in 29 (9.0%) cases. There were no in-hospital deaths; 8 (2.5%) children were admitted to an ICU; and one child developed a severe brain injury following hypoglycaemic seizure at home.
The median age of attendees was 3 (IQR 0-7) years. More than a third (39.3%, n = 126) of the patients were in the age group 1-4 years (Table 1 ). An infection was diagnosed in 42.7% (n = 137), with 52 (16.2%) having a diagnosis of gastroenteritis (Table 1) .
More infections were identified as viral (34.0%, n = 109) than bacterial (5.3%, n = 17). Hypotension was noted in 5.9% (n = 19) and 11.8% (n = 38) had reduced consciousness/unconsciousness.
Hyponatraemia was more common than hyperkalaemia (12.8%, n = 41 and 6.2%, n = 20, respectively). Hypoglycaemia was identified in 27 (8.4%) of the patients, and a seizure was reported in 13 (4.1%). The most common symptom was vomiting, which was reported in 196 (61.1%) of the attendances, while diarrhoea was recorded in 78 (24.3%) and a prodromal illness was noted in 189 (58.9%) ( Table 1 ). The mean number of signs and symptoms per presentation to hospital was 1.27 ± 0.98, and this did not differ significantly between the hospitals (Table 2) (n = 59) of patients with diarrhoea (Table 3) . One-third (32.7%, n = 64) of the children with vomiting were given IM hydrocortisone prior to hospital attendance, with 41.3% (n = 81) using oral only (Table 3) . Similarly, fewer patients with diarrhoea used IM hydrocortisone (24.4%, n = 19) than oral (51.3%, n = 40) ( Table 3) . IM hydrocortisone use was significantly associated with the diagnosis of an AC (18.3% (n = 13)) of patients using IM were classified as having an AC compared with 6.4% (n = 16), P < 0.01). By comparison, there was no significant association between oral stress dose use or use of all types of stress dose and AC incidence (both P > 0.05).
Adrenal crises incidence did not differ by age group but use of stress dosing did (P < 0.02), being used most commonly in children aged 1-4 years (73.0%, n = 92). By comparison, both IM and IV hydrocortisone use varied significantly by age group (P < 0.04 and <0.03, respectively) and were used more often in older patients (Table 1) . Children aged 1-4 years had the highest levels of prodromal illness (67.5%, n = 85) and the lowest proportion (58.7%, n = 74) of admissions (Table 1) . Hyperkalaemia was more common in children under 12 months (17.3%, n = 14) ( Table 1) .
Admission for acute illness and use of stress dosing varied significantly by hospital (P < 0.001 and P < 0.01, respectively).
Hospital C admitted the largest proportion (80.4%, n = 86) of patients and had the highest proportion of patients using stress doses (75.7%, n = 81) ( Table 2) . Patients who were admitted had a significantly higher mean number of signs and symptoms of AI than those who were treated as outpatients only (1.40±0.95 vs.
0.98±0.98) ( Table 4 ). There were also substantial differences between the hospitals in the use of IM hydrocortisone (P < 0.001), with 45.8% (n = 49) of the patients at Hospital C using IM hydrocortisone compared with 7.0% (n = 11) of the patients in Hospital A ( Table 2) . This difference was maintained even when only those records in which there was a definitive note of stress dosing were included (47.6% compared to 8.8%, P < 0.01). ACs were most commonly recorded in patients attending Hospital C (15.9%, n = 17) (P < 0.01), and this hospital had the highest use of IV hydrocortisone (69.2%, n = 74) (P < 0.001). vomiting was associated with IV hydrocortisone administration, as was the increased number of signs and symptoms of acute AI (Table 5) .
| Predictors of AC and CAH management
Increasing age was also associated with IV hydrocortisone treatment
[OR for each year of age of 1.10 (95% CI 1.04-1.17)] (Table 5 ).
| D ISCUSS I ON
The results of this comprehensive study of morbidity in paediatric CAH demonstrate that affected children experience significant illness episodes and that AC events still occur, being diagnosed in 9% of the hospital attendees. Two-thirds of the presentations resulted in admission and IV hydrocortisone was administered to half the children who attended hospital. Overall, glucocorticoid stress management of any kind was used by 64.2% of the patients, with exclusively oral dose escalation employed by 41.7% and parenteral hydrocortisone used by 22.1%. While there were some differences in presentation and treatment according to the age of the child, greater variation was found between the hospitals with regard to both prehospital management and in-hospital care. Use of IM hydrocortisone was positively associated with the number of previous hospital attendances for acute care. Treatment in hospital was successful, as there were no in-hospital deaths, although one child sustained a neurological injury.
In this study, the incidence of ACs differed significantly between the hospitals. This variation may be due to patient factors and severity of illness or more probably reflects differences between clinicians in the classification of AI-related illness as an AC.
Disparities between clinicians appear in this study to be more likely given that the symptom scores did not differ between the hospitals, although differences in severity of individual symptoms
were not assessed. The definition of an AC has been shown to vary substantially between studies in both adult and paediatric patients, encompassing the classification of relatively mild illness as an AC to the inclusion of only severe episodes.
9,14-16
Cardiovascular compromise, manifest by hypotension or other features of circulatory collapse in children, is generally agreed to be the key physiological feature of an AC. [14] [15] [16] 25 However, in this study, hypotension was not significantly associated with an AC diagnosis and was reported in fewer than 6% of the patients.
Electrolyte abnormalities and hypoglycaemia are also common features of an AC in children 15 but there was a relatively low incidence of those in this study. Although hypoglycaemia was found to be associated with an AC on bivariate analysis, it was not a significant predictor of AC in multivariate logistic regression models due to its association with reduced consciousness/unconsciousness, which was the only predictor, other than the treating hospital, of an AC diagnosis.
Patient age was associated with the management of symptomatic AI in this study, with stress management strategies used less commonly by parents of children under 12 months than those with older children. Similarly, IV hydrocortisone was given less often to children in the youngest age group than to older patients. This suggests that parents are less able to manage intercurrent illness in their very young children and are more reliant on assistance from a health service than parents of older children. These results are consistent with research by Fleming et al 21 which demonstrated that the parent's confidence and their ability to assess the severity of their child's illness were integral to their capacity to manage an acute illness episode. Improvement in the child's ability to articulate their symptoms with increasing age was also found to assist the family's management of the illness. 21 Paradoxically, there were higher rates of IV hydrocortisone use in adolescents in this study, which may reflect nonadherence to their glucocorticoid regimens, as older children with CAH attempt to take a greater role in managing their own treatment.
2,26
While gastroenteritis was formally diagnosed in 16.2% of the children, vomiting, which is also a symptom of symptomatic AI or an AC, was present in a substantially more (61.1%) patients and was significantly associated with hospital admission. Previous reviews have emphasized the importance of parenteral glucocorticoids in the context of vomiting, as this symptom can preclude or impair the absorption of oral therapy. [15] [16] [17] 26 Although vomiting was a predictor of both IM and IV hydrocortisone use in the present study, only a third (32.7%) of the children with this symptom were given parenteral hydrocortisone prior to presentation and approximately 40% were given oral hydrocortisone only, with some parents making repeated unsuccessful attempts at its administration. In this analysis, a record of a prodromal illness was associated with an increased use of oral stress dosing and a decreased use of parenteral therapy. As most of these illnesses were viral respiratory tract infections, this is consistent with recommended practice. 3, 15, 16, 19, 27 While the estimates of stress dosing cannot be used to infer the appropriateness of the decision in each circumstance in this study, the lower than expected use of IM hydrocortisone in the presence of vomiting suggests that there may be opportunities for improvement in prehospital management of ill children with CAH.
There were differences between the three health services with regard to the prehospital use of both forms of stress dosing, particularly the use of IM hydrocortisone, in which there was a 6-fold variation in usage from 7.0% to 45.8% of the presentations. Disparities between the health services were also observed in the use of IV hydrocortisone and the rates of hospital admission. a One patient had a record of stress dosing without a specification about the type of administration. Therefore, the number of patients reporting any form of stress dosing does not correspond to the sum of the other variables.
and AC events have been found to occur even among well-educated patients. 17, 28 Patients at each hospital in this study had all been given education on stress management, which typically involves instruc- 
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